Peak Pharma Reports Initial Canna-Pet Revenue with 72.7% Gross Margin

With hemp-based CBDs excluded from the DEA's Schedule I Controlled ... Peak Pharmaceuticals' hemp-based CBD-infused Canna-Pet™ products.



from Google Alert - cbd hemp http://ift.tt/1Blj6WN

via IFTTT ** Interested in building your own business with hemp? Go now! http://ift.tt/SbMGZP **